Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types (vol 25, pg 801, 2017)

Abstract

Unfortunately, the original version of this article contained errors. The names of Sung Yong Lee and Cho Eun Kim were incorrectly captured and are now corrected in this article. Affiliation 12 is also corrected. The baseline demographics table (Table 2) incorrectly reported percentages calculated out of the total population in each chemotherapy group, instead of out of the total population (as with the rest of the table). Below are the correct percentages: (Table presented). © 2017, Springer-Verlag Berlin Heidelberg.